BIOPHARMA
ByIs Gilead’s Experimental HIV Treatment Matching the Efficacy of Its Blockbuster Drug in Late-Stage Trials?
Foster City, California — Gilead Sciences has reported that its experimental HIV treatment has met the primary goal…
Is the White House (Trump) Expanding Its Drug Price Reduction Strategy with the Largest Round of Agreements Yet?
Washington, D.C. — The U.S. administration has announced a new set of agreements with nine pharmaceutical companies to…
Is Sanofi Strengthening Its Alzheimer’s Pipeline with a $1.04 Billion Partnership with South Korea’s ADEL?
Paris – Sanofi, the global pharmaceutical company, has announced a strategic collaboration with South Korea-based biotech ADEL to…
Could Roche’s Giredestrant Become the New Standard for Early-Stage ER-Positive Breast Cancer?
Basel, Switzerland – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the Phase III lidERA…
Will Novo Nordisk Pull Ahead of Eli Lilly with FDA Approval of Oral Wegovy?
The U.S. Food and Drug Administration (FDA) has approved the first daily oral version of the obesity drug…
Is Tanya Alcorn Poised to Transform Pfizer’s Global Hospital and Biosimilars Strategy?
Pfizer has appointed Tanya Alcorn as President, Global Hospital and Biosimilars, expanding her leadership responsibilities after serving more…
